Geode Capital Management
PBM icon

Geode Capital Management’s Psyence Biomedical PBM Stock Holding History

Geode Capital Management’s Portfolio PBM Stock Details PBM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3
Closed -$1.05K – 4518
2024
Q3 		$1.05K Hold
3
– – ﹤0.01% 4533
2024
Q2 		$3.15K Hold
3
– – ﹤0.01% 4581
2024
Q1 		$12K Buy
+3
New +$12.5K ﹤0.01% 4537

Other funds holding PBM

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
HCI
Harraden Circle Investments New York $499M AUM 24.03% 1-Year Est. Return
EP
Essential Planning Portsmouth, New Hampshire $315M AUM 11.68% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Geode Capital Management's PBM Position: Q4 2024 in Review

Geode Capital Management sold out of Psyence Biomedical (PBM) in Q4 2024, closing a stake of 3 shares — an estimated $1.05K sold.

Geode Capital Management first reported a position in PBM in Q1 2024 and held it in 3 quarters. The position peaked at $12K in Q1 2024. 11 funds tracked by Wall St. Rank hold PBM as of Q4 2024.

  • Geode Capital Management reported no remaining Psyence Biomedical position as of Q4 2024 after selling out during the quarter.
  • Geode Capital Management sold 3 Psyence Biomedical shares in Q4 2024, an estimated $1.05K.
  • Geode Capital Management first reported a position in Psyence Biomedical in Q1 2024 and held it in 3 quarters.
  • Geode Capital Management's Psyence Biomedical position peaked at $12K in Q1 2024.
  • 11 funds tracked by Wall St. Rank held Psyence Biomedical as of Q4 2024.

Based on Geode Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.